Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime

Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime

Experts discuss the evidence supporting the continuous relationship between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD), as recognized by the National Lipid Association, and explore how Lp(a) levels may change throughout a person’s lifetime or in response to lifestyle factors.

The Tyrolean scientist Florian Kronenberg demands that the systematic measurement of lipoprotein(a) - for short Lp(a) - mirror be included in the national health plan. This plays a role, for example, in the case of increased heart attack risk and strokes. Austria could save over half a billion euros in costs in the health sector by such a measure and avoid around 12,000 heart attacks and strokes, Kronenberg said in the APA interview.